Drug resistance is a major challenge in cancer treament, whereby cancer cells evolve to withstand the effects of chemotherapy and other targeted...
Next-generation sequencing (NGS) plays a pivotal role in the discovery and development of therapeutic T cell receptors (TCRs).
The key to the production of monoclonal antibodies (mAbs) lies in a specialized cell type known as a hybridoma.
Brentuximab Vedotin works by targeting and binding to a protein known as CD30 on cancer cells.
Trastuzumab emtansine (T-DM1) is a combination of the chemotherapy drug called emtansine and the monoclonal antibody trastuzumab.
CD30 is expressed in some tumor cells, making it a potential target for cancer immunotherapy.
In normal cells, HER2 helps to regulate cell growth and division. However, in HER2-positive breast cancer, the cells produce too much of this protein.
Antibody-drug conjugates (ADCs) are therapeutic agents that consist of monoclonal antibodies that are linked to a small-molecule drug or a cytotoxic...
Whether you're a CRO making customer deliveries, a start-up advancing towards IND, or an established biopharma supporting multiple programs at once, Affinity supports every team, at every step, on a single platform, for a single price.